Delafloxacin: First Global Approval.

about

Delafloxacin: First Global Approval.

Item

http://www.wikidata.org/entity/Q40117757

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Delafloxacin: First Global Approval.

@en

type

Item

label

Delafloxacin: First Global Approval.

@en

prefLabel

Delafloxacin: First Global Approval.

@en

P1476

Delafloxacin: First Global Approval.

@en

P2093

Anthony Markham

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

A thorough QT study to evaluate the effects of therapeutic and supratherapeutic doses of delafloxacin on cardiac repolarization.

A randomized, double-blind, Phase 2 study to evaluate subjective and objective outcomes in patients with acute bacterial skin and skin structure infections treated with delafloxacin, linezolid or vancomycin

In Vivo Pharmacodynamic Target Assessment of Delafloxacin against Staphylococcus aureus, Streptococcus pneumoniae, and Klebsiella pneumoniae in a Murine Lung Infection Model.

In Vitro Activity of Delafloxacin and Microbiological Response against Fluoroquinolone-Susceptible and Nonsusceptible Staphylococcus aureus Isolates from Two Phase 3 Studies of Acute Bacterial Skin and Skin Structure Infections

The Pharmacokinetics of the CYP3A Substrate Midazolam After Steady-state Dosing of Delafloxacin.

Clinical Pharmacology of Delafloxacin in Patients With Hepatic Impairment.

In Vitro Activity of Delafloxacin against Contemporary Bacterial Pathogens from the United States and Europe, 2014

A randomized phase 2 study comparing two doses of delafloxacin with tigecycline in adults with complicated skin and skin-structure infections.

Single and Multiple Ascending-dose Studies of Oral Delafloxacin: Effects of Food, Sex, and Age.

P2888

s40265-017-0790-5

P31

scholarly article

review article

P356

10.1007/S40265-017-0790-5

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2017-07-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2017-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1090895027

http://www.w3.org/2001/XMLSchema#string

P698

28748399

http://www.w3.org/2001/XMLSchema#string

P921

bacterial infectious disease

P932

6208769

http://www.w3.org/2001/XMLSchema#string

Delafloxacin: First Global Approval.

about

Delafloxacin: First Global Approval.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P2888

P31

P356

P5008

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P2888

P31

P356

P5008

P577

P6179

P698

P921

P932